GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
galena biopharma (GALE) [hlAlert]

Rating:
Mkt Outperform
GALE
down 43.34 %

galena biopharma (GALE) rated Mkt Outperform by JMP Securities

Posted on: Wednesday,  May 22, 2013  8:25 AM ET by JMP Securities

JMP Securities rated Mkt Outperform galena biopharma (NASDAQ: GALE) on 05/22/2013, when the stock price was $2.63.
Since then, galena biopharma has lost 43.35% as of 01/21/2016's recent price of $1.49.
If you would have followed this JMP Securities's recommendation on GALE, you would have lost 43.34% of your investment in 974 days.

RXi Pharmaceuticals Corporation (RXi) is a discovery-stage biopharmaceutical company pursuing therapeutics based on ribonucleic acid interference (RNAi) for the treatment of human diseases. The Company is focused on internal research and development programs on certain inflammatory and metabolic diseases, and to pursue other therapeutic areas with potential partners. RXi commenced operations after CytRx Corporation contributed to the Company its portfolio of RNAi therapeutic assets, which consisted primarily of RNAi licenses and related intellectual property, and a nominal amount of equipment. As of December 31, 2008, the Company had not generated any revenues.

MP Securities' equity research department provides institutional clients with comprehensive industry knowledge, unique insight and actionable information. JMP's senior research analysts are charged with developing proprietary investment themes, anticipating secular and cyclical changes and producing action-oriented reports. JMP follows companies in six industries that exhibit above-average long-term growth characteristics — Technology, Healthcare, Consumer, Real Estate, Financial Services and Business Services — and produces specialized equity research that enables investors to understand and invest in complicated growth stocks profitably.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/22/2013 8:25 AM Buy
None
2.63
as of 12/13/2013
1 Week down  -6.54 %
1 Month up  38.00 %
3 Months up  113.40 %
1 YTD up  57.41 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy